Acamprosate for Alcohol Addiction

Key Takeaways

• Acamprosate, brand name Campral, is an FDA-approved medication for treating alcohol use disorder by reducing cravings and relapse risk.
• It functions as a neuromodulator, restoring balance between excitatory and inhibitory neurotransmitters in the brain.
• Acamprosate is most effective when used alongside counseling and psychosocial support.
• The drug is excreted unchanged by the kidneys. Therefore, it is suitable for patients with liver issues but not for those with severe renal impairment.
• Common side effects include gastrointestinal problems like diarrhea, while severe side effects may include mood changes and suicidal thoughts.
• Comparative studies show acamprosate is as effective as naltrexone in promoting abstinence, with neither drug being superior overall.
• It is recommended by authoritative bodies as a preferred pharmacologic option for alcohol use disorder, in combination with behavioral interventions.
• Acamprosate’s safety profile is generally good, but patients should be monitored for potential side effects.
• Understanding individual patient factors is crucial in choosing Acamprosate over other alcohol use disorder treatments.
• It plays a significant role in managing alcohol dependence, especially when combined with psychosocial interventions.

Acamprosate’s Role in Treating Alcohol Addiction

Acamprosate is often known under the brand name Campral. It is a medication prescribed to support individuals recovering from alcohol addiction. 

Approved by the FDA in 2004, it functions as a neuromodulator. That means it aids those who have stopped drinking alcohol by reducing cravings and the likelihood of relapse. Notably, acamprosate is most effective when used with counseling and psychosocial support. It operates by restoring the balance between different neurotransmitters in the brain, which are disrupted by alcohol use.

The drug is believed to help stabilize brain chemistry after an individual stops drinking. In turn, it mitigates symptoms associated with post-acute withdrawal, such as sleep disturbances and mood fluctuations. Acamprosate’s chemical structure is similar to that of the neurotransmitter GABA, which reduces neuronal excitability throughout the nervous system.

Acamprosate is not metabolized by the body. Therefore, it is excreted unchanged, primarily through the kidneys. It has a low bioavailability, and its absorption and elimination is relatively slow. This contributes to its steady presence in the system during treatment. 

The medication is well-tolerated by most patients, but it does come with potential side effects. Diarrhea is the most common side effect. However, there is the risk of more serious side effects, like allergic reactions or abnormal heart rhythms. It should not be taken by individuals with severe renal impairment or those with a known allergy to its components.

Unfortunately, acamprosate’s precise mechanism is not fully understood. Nevertheless, it is recognized for its ability to support the maintenance of sobriety by addressing the neurochemical changes caused by alcohol dependence. 

Acamprosate in Alcohol Addiction Treatment

Acamprosate is a medication that plays a significant role in the treatment of alcohol addiction. Its primary use is to support individuals in maintaining abstinence from alcohol post-detoxification. 

Research has shown that acamprosate significantly reduces the risk of relapse into drinking and increases the cumulative duration of abstinence. It is especially valued given the chronic relapsing nature of alcoholism and the limited options available for its treatment.

Acamprosate has been compared to other medications, such as naltrexone. Interestingly, studies suggest that neither drug is superior in preventing relapse. However, acamprosate’s advantage lies in its ability to modulate and normalize brain activity changes related to alcohol. This helps alleviate post-acute withdrawal symptoms that can trigger relapses, such as disturbances in sleep and mood. Its safety profile is considered good and can be effectively combined with psychosocial treatment strategies to enhance outcomes.

While acamprosate’s mechanism of action is not fully understood, its impact on brain chemistry is valuable. It appears to reduce cravings and ease withdrawal discomfort, contributing to improved abstinence rates in clinical trials. Given its effectiveness and safety, acamprosate is recommended by many authoritative bodies as a preferred pharmacologic option for alcohol use disorder. However, it is recommended in combination with cognitive behavioral interventions.

Effectiveness of Acamprosate in Treating Alcohol Addiction

Acamprosate has been the subject of numerous studies to determine its efficacy. 

A meta-analysis that included 64 randomized, placebo-controlled studies found acamprosate to be more effective than placebo in promoting abstinence from alcohol. Another study, a 12-month randomized, double-blind trial, supported these findings, showing that acamprosate at two different dose levels significantly aided in maintaining abstinence in alcohol-dependent patients post-detoxification.

Further research indicates that when combined with psychosocial interventions, acamprosate leads to higher abstinence rates and longer cumulative abstinence duration compared to placebo. This medication is considered safe and well-tolerated, having been used to treat over 1.5 million patients since 1989.

Comparative studies between acamprosate and naltrexone show that neither has definitive superiority over the other. Both medicines have strong evidence supporting their use in reducing alcohol consumption, but individual responses can vary. The largest randomized controlled trial, the COMBINE study, found that acamprosate combined with naltrexone produced significant cost savings and increased the proportion of patients with good clinical outcomes, including abstinence and avoidance of heavy drinking.

Side Effects of Acamprosate

While acamprosate can help prevent relapse, patients and healthcare providers must be aware of its potential side effects. As with any medication, the risk of side effects must be weighed against the benefits of its use in treating alcohol addiction. Acamprosate is generally well-tolerated, but its side effects can vary from person to person.

Common Side Effects of Acamprosate

The most frequently reported side effect of Acamprosate is diarrhea. Understandably, this can significantly impact a patient’s comfort and adherence to the medication. Other common side effects include nausea, itching, sweating, and trouble sleeping. Patients may also experience anxiety or nervousness, loss of appetite, and low energy levels.

Although less common, some individuals may encounter more serious side effects such as depression and suicidal thoughts or behavior. It is crucial for healthcare providers to monitor patients closely for these severe side effects and to provide appropriate interventions when necessary. 

Additionally, patients with kidney disease or a history of suicidal thoughts or attempts should use acamprosate with caution. Unfortunately, these conditions may exacerbate the side effects or affect the medication’s efficacy.

Severe Side Effects of Acamprosate

Severe side effects include mental and mood changes such as depression and suicidal thoughts or behaviors. Patients may also experience fainting, a fast or pounding heartbeat, vision or hearing changes, and increased thirst. Crucially, this last symptom can indicate other more significant health issues.

Some rare but very serious side effects include:

• Seizures.
• Persistent stomach pain.
• Black or tarry stools.
• Vomit that looks like coffee grounds, suggesting gastrointestinal bleeding. 

Though unlikely, an allergic reaction to acamprosate can occur. It may present with symptoms such as difficulty breathing, skin rash, itching, swelling, or severe dizziness. In cases of overdose, diarrhea has been reported as a symptom associated with acamprosate.

Patients and caregivers must immediately monitor for these severe side effects and report them to a healthcare provider. The presence of such symptoms may necessitate a re-evaluation of the treatment plan. As with any medication, the benefits of acamprosate must be weighed against the potential risks, and decisions should be made in close consultation with a healthcare professional.

Efficacy of Acamprosate vs. Alternative Alcohol Addiction Treatments

Comparing the efficacy of acamprosate to other treatments for alcohol addiction reveals nuanced results tailored to specific treatment goals. 

According to a comparative study, acamprosate, naltrexone, and baclofen have all been recognized for their effectiveness in managing alcohol dependence. Importantly, this is instrumental in developing relapse-prevention strategies. Specifically, acamprosate is more effective for inducing abstinence, while naltrexone shows better results in reducing heavy drinking and cravings. This was highlighted in a BMJ Mental Health Review, which indicated that acamprosate had a significantly greater overall effect size for abstinence compared to naltrexone.

Moreover, a systematic review found moderate evidence for using acamprosate and oral naltrexone to reduce the return to drinking and the percentage of drinking days. Notably, the “number needed to treat” to prevent one person from returning to drinking was 11 for acamprosate and 18 for oral naltrexone, suggesting a slightly higher efficacy for acamprosate.

Overall, while Acamprosate and naltrexone are both effective for treating alcohol use disorder (AUD), their relative strengths depend on the treatment objectives—whether the aim is to foster abstinence or to mitigate heavy drinking and cravings. This distinction is crucial for healthcare providers when tailoring treatment plans to individual patient needs.

Side Effects of Acamprosate vs. Other Alcohol Addiction Treatments

Acamprosate requires a high pill burden, as it is typically taken as two tablets three times daily. In contrast, naltrexone may cause more significant side effects but is also effective in reducing heavy drinking and cravings. 

Other medications, such as gabapentin and topiramate, are prescribed off-label for alcohol use disorder. However, they have less evidence supporting their efficacy and may come with more potential side effects. Disulfiram, another FDA-approved treatment for alcohol use disorder, works by causing unpleasant effects when alcohol is consumed. Therefore, it can lead to severe reactions if alcohol is ingested. It’s important for patients to be aware of the side effects associated with each medication and to discuss these with their healthcare provider when considering treatment options for alcohol addiction.

Patients taking acamprosate should be vigilant for any signs of suicidal thoughts and contact their provider immediately if they occur. While acamprosate is generally well-tolerated, it is unsuitable for individuals with known allergies to acamprosate calcium or other ingredients. Similarly, naltrexone is contraindicated in patients with hepatic failure, acute hepatitis, or those who have recently used opioids.

Recovering From Alcohol Addiction in Salem, Oregon: The Recovery Center, Salem

If you or a loved one struggles with addiction or a mental health disorder, The Recovery Village Salem is here to help. Our physician-led, evidence-based rehab programs include medical detox, residential rehab and a wide range of therapies. Our compassionate team will help you start life fresh with the tools, coping strategies and resources you need to succeed. Don’t wait — contact a Recovery Advocate today to see how we can help.